title: Attitudes toward metabolic adverse events among patients with schizophrenia in Japan.
abstract: BACKGROUND
  Metabolic syndrome is a growing concern among patients with schizophrenia because metabolic abnormalities are widely regarded as a major risk factor for cardiovascular disease and premature death. The current study assessed attitudes toward metabolic adverse events among patients with schizophrenia.
  
  
  METHODS
  A brief questionnaire was constructed to investigate patient recognition of the following broad areas: dietary habits, lifestyle, self-monitoring, knowledge, and medical practice. Between January 2012 and June 2013, questionnaires were sent to patients associated with 520 outpatient facilities and 247 inpatient facilities belonging to the Japan Psychiatric Hospital Association. All of the participants (n=22,072; inpatients =15,170, outpatients =6,902) were diagnosed with schizophrenia based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, or the International Classification of Diseases, tenth revision.
  
  
  RESULTS
  Approximately 55.0% (8,069/14,669) of inpatients and 44.8% of outpatients (2,978/6,649) reported that they did not exercise at all. Although 60.9% (4,116/6,760) of outpatients reported that they felt obese, only 35.6% (5,261/14,794) of inpatients felt obese. More than half of the inpatients (51.2%; 7,514/14,690) and outpatients (60.8%; 4,086/6,721) hoped to receive regular blood tests to prevent weight gain and diseases such as diabetes.
  
  
  CONCLUSIONS
  Although more than half of patients hoped to prevent weight gain and diabetes, only a minority of patients were mindful of eating balanced meals and having physical exercise. Educational efforts and the promotion of the best pharmacotherapy and monitoring practices are needed for patients with schizophrenia.
authors.affiliation: Aomori Prefectural Center for Mental Health and Welfare, Aomori, Japan; Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan; Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan.
authors.forename: Norio
authors.initials: N
authors.lastname: Sugawara
authors.affiliation: Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan; Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan.
authors.forename: Norio
authors.initials: N
authors.lastname: Yasui-Furukori
authors.affiliation: Japan Psychiatric Hospital Association, Tokyo, Japan.
authors.forename: Manabu
authors.initials: M
authors.lastname: Yamazaki
authors.affiliation: Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan; Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan.
authors.forename: Kazutaka
authors.initials: K
authors.lastname: Shimoda
authors.affiliation: Japan Psychiatric Hospital Association, Tokyo, Japan.
authors.forename: Takao
authors.initials: T
authors.lastname: Mori
authors.affiliation: Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan; Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
authors.forename: Takuro
authors.initials: T
authors.lastname: Sugai
authors.affiliation: Japan Psychiatric Hospital Association, Tokyo, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Matsuda
authors.affiliation: Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan; Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
authors.forename: Yutaro
authors.initials: Y
authors.lastname: Suzuki
authors.affiliation: Japan Psychiatric Hospital Association, Tokyo, Japan.
authors.forename: Yoshitake
authors.initials: Y
authors.lastname: Minami
authors.affiliation: Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan; Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan.
authors.forename: Yuji
authors.initials: Y
authors.lastname: Ozeki
authors.affiliation: Japan Psychiatric Hospital Association, Tokyo, Japan.
authors.forename: Kurefu
authors.initials: K
authors.lastname: Okamoto
authors.affiliation: Department of Health and Nutrition, Yamagata Prefectural Yonezawa University of Nutrition Sciences, Yonezawa, Japan.
authors.forename: Toyoaki
authors.initials: T
authors.lastname: Sagae
authors.affiliation: Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan; Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Someya
keywords: Japan; attitude; metabolic syndrome; schizophrenia